特殊健康儿童预防接种评估及不良反应处理

doi:10.3969/j.issn.1000-8535.2023.10.006

广州医药 ›› 2023, Vol. 54 ›› Issue (10): 46-51.DOI: 10.3969/j.issn.1000-8535.2023.10.006

特殊健康儿童预防接种评估及不良反应处理

王富云, 刘桂红

广州市社会福利院康复医院（广东广州 510520)

收稿日期:2023-05-17 出版日期:2023-10-20 发布日期:2023-11-07
通讯作者: 刘桂红,E-mail：459731687@qq.com
基金资助:
广州市卫生健康科技项目（2022 1A011110）

Vaccination evaluation and adverse reaction management of healthy special children

WANG Fuyun, LIU Guihong

Guangzhou Social Welfare Institute Rehabilitation Hospital, Guangzhou 510520, China

Received:2023-05-17 Online:2023-10-20 Published:2023-11-07

摘要/Abstract

摘要： 目的探讨特殊健康儿童预防接种评估及不良反应处理。方法选取2018年1月–2022年12月经预防接种门诊主动筛选的出生日期在2004年6月1日—2022年6月1日的特殊健康儿童,收集临床资料,以此进行预防接种评估建议,随访不良反应。结果本研究共纳入944例特殊健康儿童,其中精神发育迟滞231例（24.47%）、脑性瘫痪440例（46.61%）、先天愚型115例（12.18%）、癫痫74例（7.83%）、先天性心脏病54例（5.72%）、唐氏综合征30例（3.18%）。其中男、女分别有519例（54.98%）、425例（45.02%）。在特殊健康儿童中,建议可正常接种疫苗918例（97.25%）,建议接种灭活疫苗但避免接种减毒活疫苗8例（0.85%）,建议暂缓接种所有疫苗18例（1.91%）。建议接种疫苗的特殊健康儿童中,已接种疫苗926例（98.09%）,接种灭活疫苗842例（89.19%）,接种减毒活疫苗612例（64.83%）;926例儿童共接种疫苗8 480剂次,其中灭活疫苗6 770剂次、减毒活疫苗1 770剂次;62例儿童进行68剂次疫苗接种后出现不良反应（包括局部反应15例次、全身反应53例次）,总发生率为8.02‰（68/8 480）,其中灭活疫苗、减毒活疫苗发生率分别为6.79‰（46/6770）、1.29%（22/1 710）。所有不良反应案例经处理,除口干1例处理后好转外,其他均达治愈,治愈率达98.53%（67/68）。结论特殊健康儿童经医学评估后大多可接种疫苗,接种后不良反应发生风险在可控范围内。

关键词: 特殊健康儿童, 预防接种评估, 不良反处理

Abstract: Objective To discuss the evaluation of vaccination and treatment of adverse reactions in healthy special children. Methods From January 2018 to December 2022,healthy special children with birth dates from June 1,2004 to June 1,2022 who were screened by the vaccination clinic were selected. Clinical data were collected to conduct vaccination assessment recommendations and follow up adverse reactions. Results A total of 944 healthy special children were included in this study,including 231 cases(24. 47%)of mental retardation,440 cases(46. 61%)of cerebral palsy,115 cases(12. 18%)of congenital foolishness,74 cases(7. 83%)of epilepsy,54 cases(5. 72%)of congenital heart disease and 30 cases(3. 18%)of Down syndrome. There were 519 males(54. 98%)and 425 females(45. 02%). Among the healthy special children,918 cases(97. 25%)were recommended to get vaccinated normally,8 cases(0. 85%)were recommended to be vaccinated with inactivated vaccine but avoid to be vaccinated with attenuated live vaccine,and 18 cases(1. 91%)were recommended to suspend all vaccination. Among the special healthy children recommended for vaccination,926(98. 09%)had been vaccinated,842(89. 19%)had been vaccinated with inactivated vaccine,and 612(64. 83%)had been vaccinated with live attenuated vaccine. A total of 8 480 doses of vaccines were administered to 926 children,including 6 770 doses of inactivated vaccines and 1 770 doses of attenuated live vaccines. Adverse reactions occurred in 62 children after 68 doses of vaccination(including 15 cases of local reactions and 53 cases of systemic reactions),with a total incidence of 8. 02 ‰(68/8480). The incidences of inactivated vaccine and attenuated live vaccine were 6. 79 ‰(46/6 770)and 1. 29%(22/1710),respectively. All cases of adverse reactions were treated and basically cured,with a cure rate of 98. 53%(67/68),except for the case of dry mouth. Conclusions Most of the healthy special children can be vaccinated after medical evaluation,and the risk of adverse reactions after vaccination is controllable.

Key words: healthy special children, vaccination assessment, adverse reactions management

王富云, 刘桂红. 特殊健康儿童预防接种评估及不良反应处理[J]. 广州医药, 2023, 54(10): 46-51.

WANG Fuyun, LIU Guihong. Vaccination evaluation and adverse reaction management of healthy special children[J]. Guangzhou Medical Journal, 2023, 54(10): 46-51.

参考文献

[1] 余文周,叶家楷,吴静,等.中国免疫规划面临的挑战和发展建议[J].中国疫苗和免疫,2020,26(5):574-577.
[2] 沈妍琼,仇静,郭翔,等.上海市预防接种人员对特殊健康状态儿童疫苗接种的认知调查[J].中国疫苗和免疫,2023,29(1):76-81.
[3] 宋渝丹,黎祺,黄勇,等.中国特殊健康状态儿童疫苗接种研究进展[J].中国疫苗和免疫,2022,28(5):595-600.
[4] 韩英,胡丹丹,韦茹,等.广东省特需人群接种门诊特殊健康状态儿童预防接种探索[J].中国疫苗和免疫,2021,27(6):678-683.
[5] KEMPE A,ALLISON M A,MACNEIL J R,et al.Knowledge and attitudes regarding category B ACIP recommendations among primary care providers for children[J].Acad Pediatr,2018,18(7):763-768.
[6] National Health Commission of The People’s Republic of China.Childhood immunization schedule for national immunization program vaccines - China(Version 2021)[J].China CDC Wkly,2021,3(52):1101-1108.
[7] 全国疑似预防接种异常反应监测方案[J].中国疫苗和免疫,2011,17(1):72-81.
[8] 李克莉,张丽娜,叶家楷,等.中国2017年疑似预防接种异常反应监测[J].中国疫苗和免疫,2020,26(1):9-18.
[9] 彭晓康,胡伟军,陈艳妮,等.陕西省特殊健康状态儿童预防接种评估门诊遗传代谢性肝病儿童预防接种研究[J].中国疫苗和免疫,2022,28(3):317-323.
[10] HE Y,LIU Y,DAI B,et al.Assessing vaccination coverage,timeliness,and its temporal variations among children in a rural area in China[J].Hum Vaccin Immunother,2021,17(2):592-600.
[11] 汤亚南. 儿童和青少年功能性神经系统疾病诊断与治疗进展[J].中国现代神经疾病杂志,2023,23(2):143-147.
[12] 李静,陈继顺,强旭,等.中国儿童精神发育迟滞致病生物因素的Meta分析[J].西北大学学报(自然科学版),2016,46(5):711-715.
[13] 王筠婷,宋贝贝,赵迪,等.脑性瘫痪儿童青少年全身振动干预的健康和功能结局:基于WHO-FICs的系统综述[J].中国康复理论与实践,2023,29(1):55-63.
[14] 胡丹丹. 神经系统疾病儿童免疫接种策略[J].临床儿科杂志,2022,40(3):184-188.
[15] 黄文胜,农初师,唐金芳,等.南宁市流动儿童预防接种工作状况分析[J].现代预防医学,2019,46(19):3528-3530.
[16] 张雪海,李娜,张双凤,等.我国第二类疫苗接种现状及其影响因素研究进展[J].中国预防医学杂志,2018,19(7):548-552.
[17] SOLMAZ I,ANLAR B.Immunization in multiple sclerosis and other childhood immune-mediated disorders of the central nervous system:A review of the literature[J].Eur J Paediatr Neurol,2021(33):125-134.
[18] DINLEYICI M,CARMAN K B,KILIC O,et al.The immunization status of children with chronic neurological disease and serological assessment of vaccine-preventable diseases[J].Hum Vaccin Immunother,2018,14(8):1970-1976.

特殊健康儿童预防接种评估及不良反应处理

Vaccination evaluation and adverse reaction management of healthy special children

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价